accounting and approval of the disposal of investmentsBS Myco Biotech Company Limited ( 2 st review) 28/12/2021 19:33 Notification of the resignation of the Company's director and appointment of a supervisor

://market.sec.or.th/public/idisc/Download?FILEID=dat/news/201905/19050122.pdf 19075462.pdf 9% Inventories 67,604 70,085 (4)% Other current assets 13,628 10,850 26% Total current assets 130,836 124,284 5% Investment

assets as of March 31, 2019 was 1,641.7 million baht, decreased 9.2 million baht or 0.6 percent compared to the total assets as of December 31, 2018. (1.1) Current Assets As at March 31, 2019 currents

March 31, 2018 was 1,615.6 million baht, decreased 24.3 million baht or 1.5 percent compared to the total assets as of December 31, 2017. (1.1) Current Assets As at March 31, 2018 currents assets amounted

production as there was no order presented, affecting the company directly during the second quarter of 2020. The situation also affected the company’s waste sent for treatment and disposal from our current

2017 and the investment in Property, Plant and Equipment. Also, the establishment of a medical international clinic including preparation for the construction of Wattanapat Ao Nang Hospital. Current

DOD BIOTECH PUBLIC COMPANY LIMITED 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 Page 1 of 3 No. DOD026/2563 February 26, 2020 Subject Management Discussion and Analysis of for

DOD BIOTECH PUBLIC COMPANY LIMITED 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 Page 1 (Translate) NO. DOD 030/2019 August 13, 2019 Subject: Clarification of the operating

DOD BIOTECH PUBLIC COMPANY LIMITED 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 Page 1 (Translate) NO. DOD 035/2019 November 11, 2019 Subject: Clarification of the operating

the first quarter of 2018, the company had a gain from the sale non-current assets held for sale in the amount of Baht 32.02 million. 1.2 The company’s income from energy business in Q1/2019 was Baht